MTEM Molecular Templates

Molecular Templates Inc is a clinical-stage biopharmaceutical company. It develops next generation immunotoxins known as Engineered Toxin Bodies for the treatment of individuals living with various cancer.

As of 11/30/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/04/2005
Outstanding shares:  56,305,049
Average volume:  209,146
Market cap:   $237,607,307
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    608550109
ISIN:        US6085501095
Sedol:      BYXC6T1
Valuation   (See tab for details)
PE ratio:   -2.30
PB ratio:   3.22
PS ratio:   9.81
Return on equity:   -16.38%
Net income %:   -48.74%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy